SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Rumor Central -- Ignore unavailable to you. Want to Upgrade?


To: Master (Hijacked) who wrote (4)5/4/1998 3:37:00 PM
From: Master (Hijacked)  Read Replies (1) | Respond to of 12
 
SUGN could be the next ENMD. From the news today:

"Several other companies are also working on other formulations of angiogenesis inhibitors."

And SUGN is in HUMAN clinical trials, not mice.

ENMD jumped from 12 to 84(options ran from 38 cents to $57 today!) based on a NY Times article. I heard a WSJ article
featuring SUGN is coming out this week...